Multicolor, Cell-Impermeable, and High Affinity BACE1 Inhibitor Probes Enable Superior Endogenous Staining and Imaging of Single Molecules.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
06 Jun 2024
Historique:
medline: 6 6 2024
pubmed: 6 6 2024
entrez: 6 6 2024
Statut: aheadofprint

Résumé

The prevailing but not undisputed amyloid cascade hypothesis places the β-site of APP cleaving enzyme 1 (BACE1) center stage in Alzheimer's Disease pathogenesis. Here, we investigated functional properties of BACE1 with novel tag- and antibody-free labeling tools, which are conjugates of the BACE1-inhibitor IV (also referred to as C3) linked to different impermeable Alexa Fluor dyes. We show that these fluorescent small molecules bind specifically to BACE1, with a 1:1 labeling stoichiometry at their orthosteric site. This is a crucial property especially for single-molecule and super-resolution microscopy approaches, allowing characterization of the dyes' labeling capabilities in overexpressing cell systems and in native neuronal tissue. With multiple colors at hand, we evaluated BACE1-multimerization by Förster resonance energy transfer (FRET) acceptor-photobleaching and single-particle imaging of native BACE1. In summary, our novel fluorescent inhibitors, termed

Identifiants

pubmed: 38842406
doi: 10.1021/acs.jmedchem.4c00339
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Florian Stockinger (F)

Institut für Physiologie und Pathophysiologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.

Pascal Poc (P)

Department of Chemical Biology, Max Planck Institute for Medical Research, Heidelberg 69120, Germany.
Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin 13125, Germany.

Alexander Möhwald (A)

Institut für Physiologie und Pathophysiologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.

Sandra Karch (S)

Institut für Physiologie und Pathophysiologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.

Stephanie Häfner (S)

Université Côte d'Azur, CNRS, INSERM, iBV, Nice 06108, Cedex 2, France.
Laboratories of Excellence, Ion Channel Science and Therapeutics, Nice 06108, Cedex 2, France.

Christian Alzheimer (C)

Institut für Physiologie und Pathophysiologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.

Guillaume Sandoz (G)

Université Côte d'Azur, CNRS, INSERM, iBV, Nice 06108, Cedex 2, France.
Laboratories of Excellence, Ion Channel Science and Therapeutics, Nice 06108, Cedex 2, France.

Tobias Huth (T)

Institut für Physiologie und Pathophysiologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.

Johannes Broichhagen (J)

Department of Chemical Biology, Max Planck Institute for Medical Research, Heidelberg 69120, Germany.
Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin 13125, Germany.

Classifications MeSH